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Objectives. We sought to determine the relations of left atrial
(LA) size to blood pressure, obesity, race, age and left ventricular
(LV) mass in hypertension.
Background. Although obesity, race and age may influence LV
mass, their effects on LA size have not been defined in hyperten-
sion.
Methods. Left atrial size was measured in 690 men (58%
African-Americans) with mild to moderate hypertension (mean
[6SD] blood pressure 152 6 15/98 6 6 mm Hg) and a high
prevalence of LV hypertrophy. Effects of LV mass, adiposity, race,
age, physical activity, height, weight, sodium excretion, plasma
renin activity and heart rate were examined.
Results. Left atrial size was greater (p <2 0.0001) in obese
(44.2 6 5.7 mm) than in overweight (41.6 6 5.9 mm) or normal
weight (38.9 6 6.2 mm) patients. Left atrial enlargement
(>243 mm) was present in 56% of obese patients compared with
42% of overweight and 25% of normal weight hypertensive men. As
age increased, white patients had a greater LA size than African-
American patients. Although there was no relation between LV
mass and LA size in normal weight patients, there was a signifi-
cant positive relation in obese patients. On multiple regression
analysis, obesity was the strongest independent predictor of
increased LA size.
Conclusions. Obesity is the strongest predictor of LA size in
patients with hypertension and amplifies the relation between LA
size and LV mass. Race influences effects of age and hypertension
on LA size. Because increased LA size and LV mass (also
influenced by obesity) are associated with an adverse outcome,
these findings underscore the importance of obesity, race and age
with regard to the cardiac effects of hypertension.
(J Am Coll Cardiol 1997;29:651–8)
q1997 by the American College of Cardiology
Left ventricular (LV) mass (1) and left atrial (LA) size (1–3)
are both increased in patients with hypertension. Although LV
mass has been shown to be a predictor of cardiovascular
events, including myocardial infarction and death, LA size is
associated with the likelihood of developing atrial fibrillation
(4,5) and stroke (6).
Recently, evaluation of a free-living, population-based co-
hort (7) showed modest relations between systolic blood
pressure, pulse pressure and echocardiographically deter-
mined LA size. The relative contribution of blood pressure to
LA size was substantially less than that of age and body mass
index. Inclusion of LV mass in statistical models of LA size
further weakened the association of blood pressure.
However, the relative contributions of blood pressure, body
weight, age and LV mass to LA size have not been determined
in patients with established hypertension. Moreover, although
it has been shown that race influences the effects of hyperten-
sion on LV wall thickness (8–11), the effects of race on LA size
in patients with hypertension are unknown. Therefore, we used
echocardiography to assess LA size in 690 men with mild to
moderate hypertension and determined the relations of LA
size to blood pressure, obesity, race and LV mass.
Methods
Patients. The patients included in the present study were
part of a cohort of 1,292 men recruited for a randomized,
prospective trial of monotherapy in mild to moderate (diastolic
blood pressure 95 to 109 mm Hg) hypertension (12) uncom-
plicated by clinically evident cardiac or systemic disease.
Systolic blood pressure ranged from 120 to 199 mm Hg.
Echocardiograms in 680 men (53%), acquired at 14 centers,
were evaluated for this study. This number reflects the product
of the overall acquisition rate (72%) and the proportion of
technically acceptable studies (75%) for the estimation of LA
size and LV mass.
Echocardiography. After 6 to 12 weeks of withdrawal of
prior antihypertensive medication (460 patients), or 4 to 12
weeks of baseline observation in the 232 patients not receiving
therapy at study entry, two-dimensional targeted M-mode
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echocardiography was performed. To minimize variability,
measurements of LA dimension, ventricular septum, LV cavity
and posterior wall dimensions from paper stripchart recordings
were taken by a single reader, using an off-line image analysis
system, according to American Society of Echocardiography
(ASE) criteria (13).
To determine LA dimension, the maximal dimension was
measured between the leading edge of the posterior aortic wall
to the leading edge of the posterior wall of the left atrium at
end-systole. Interobserver error for LA dimension, determined
by comparing 121 echocardiograms read by the core laboratory
sonographer for this study with those measurements made by
a “reference reader” (J.S.G.), was 3.2%. Intraobserver error
was 2.8% for sonographer and 1.7% for “reference” reader
measurements.
Left ventricular mass (ASE) was calculated as described
elsewhere (14). These measurements were converted to
Cornell-Penn convention values using published regression
equations (15). For determination of the presence of LV
hypertrophy, LV mass (Cornell-Penn) was indexed to body
surface area, computed by nomogram (16); 134 g/m2 was
selected as the partition value for LV hypertrophy (14). In
addition, to avoid the flattening contribution of obesity to the
estimation of LV hypertrophy prevalence, LV mass (ASE) was
also indexed to height according to the Framingham conven-
tion (17); 164 g/m was selected as the partition value for LV
hypertrophy. Echocardiographic characteristics of this group
pertinent to LV dimensions, LV mass and prevalence of LV
hypertrophy (63% Framingham criteria; 46% Cornell-Penn
criteria) have been described previously (8).
Left atrial size was analyzed as a linear dimension as well as
indexed by height in an attempt to account for allometric,
physiologic differences in LA size based on body size. Index-
ation by body surface area, as has sometimes been done, was
considered inappropriate because we wished to determine the
effects of obesity on LA size. Indexation by body surface area,
principally determined by body weight, would have interfered
with analysis of the effects of obesity on LA size.
Adiposity. Body mass (Quetelet) index was selected as a
measure of adiposity determined as weight (kg) divided by
height squared (m2). “Normal” weight was defined by body
mass index #27 kg/m2 (269 patients); “overweight” as 27 to
30 kg/m2 (200 patients); and “obesity” (223 patients) as
.30 kg/m2 (18,19). These categories have been described
elsewhere (19). In the present study, the “obesity” category
corresponds with a moderate risk of overall mortality, and
“overweight” corresponds with a 20% increase in “desirable”
weight determined from Metropolitan Life tables.
Clinical measurements. Casual blood pressure was mea-
sured with a cuff sphygmomanometer after 15 min of rest
sitting upright with the back supported. Plasma renin was
determined by iodine-125 radioimmunoassay (Clinical Assays,
Travenol Division, Genentech Diagnostics, Inc.). Physical ac-
tivity index was obtained by an administered questionnaire that
queried work and recreational physical activity for the 6-month
period preceding study recruitment. A numeric value was
derived from the estimated average duration and intensity of
activity. Sodium intake was determined from one 24-h mea-
surement of total urinary sodium excretion (mmol).
Statistical methods. All values for quantitative measures
are expressed as mean value6 SD. Left atrial enlargement was
defined as LA dimension $43 mm. This partition value was
defined by the Framingham study (7) as the 90th percentile
value in normotensive, nonobese men. Left atrial enlargement
was arbitrarily considered to be mild to moderate if the LA
dimension was between 43 and 49 mm, and severe if the left
atrial dimension was .50 mm. Comparisons of data (20) for
outcome variables (e.g., LA dimension) between two groups
(e.g., black men and white men) were performed using the
Student t test for independent groups. Comparisons across
more than two groups (e.g., normal weight, overweight, obese)
were done using analysis of variance (ANOVA) for unbal-
anced data. Pairwise comparisons of groups were made using
the Tukey procedure if the ANOVA statistic was significant at
the 0.05 level.
Correlations were obtained to assess univariate relations of
clinical variables to LA dimension, as well as indexed LA
dimension. The independent contribution of clinical descrip-
tors, including LV mass, adiposity (body mass index), race, age,
systolic blood pressure, physical activity, sodium excretion,
plasma renin activity and heart rate, to LA dimension and
indexed LA dimension was determined by stepwise multiple
regression. For multiple regression analyses, models were
created using predictor variables singly and by examining all
possible two-way interactions.
Comparison of the distribution of noncontinuous variables
across groups was accomplished using the chi-square test of
homogeneity for contingency tables. If significant differences
were present, the Grizzle-Starmer-Koch (21) approach was
used to identify which pairs of groups were different.
The statistical computer package SAS, version 6, was used
to generate the statistical analyses (20). All statistical tests
were two-tailed, and p # 0.05 was used to identify statistically
significant results.
Results
Patient characteristics. The average age of the patients
was 58 6 10 years; the average blood pressure was 152 6
15/98 6 6 mm Hg; and the average LV mass was 329 6 93 g.
Fifty-eight percent of the subjects were African-American. The
prevalence of LV hypertrophy was 63% by Framingham
Abbreviations and Acronyms
ANOVA 5 analysis of variance
ASE 5 American Society of Echocardiography
LA 5 left atrial
LV 5 left ventricular
SHEP 5 Systolic Hypertension in the Elderly Program
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criteria and 46% by Cornell-Penn criteria. Baseline height,
weight and echocardiographic characteristics subset by age and
race are shown in Table 1. Within each age group there were
no significant differences for any of the characteristics.
Left atrial dimension and enlargement. For all patients the
average LA dimension was 41.4 6 6.4 mm (range 20 to 63),
whereas indexed LA dimension averaged 23.5 6 3.6 mm/m
(range 11.6 to 36.5). Left atrial enlargement was noted in 271
men (40%). Of these, 210 men (77%) had mild to moderate
enlargement (average 45.96 1.9, range 43 to 49) and 61 (23%)
had severe enlargement (average 52.8 6 3.0 mm, range 50 to
63).
The strongest correlations of LA size (Fig. 1) were, in
decreasing order, with body weight, body mass index, LV mass,
LV cavity dimension, height, septal thickness and posterior
wall thickness. Correlations were not significant with systolic
blood pressure, diastolic blood pressure, age, plasma renin
activity, heart rate, sodium excretion or physical activity score.
For indexed LA size (Fig. 1), correlations were strongest for
body mass index, body weight, LV mass, LV cavity dimension,
height (negative), septal thickness, systolic blood pressure and
age. Relations were not significant with plasma renin activity,
heart rate, posterior wall thickness, diastolic blood pressure,
physical activity or sodium excretion.
Relation of obesity to left atrial size. Left atrial size (Fig. 2,
top) differed significantly (p # 0.0001 by ANOVA) across
obesity categories. Based on the Tukey procedure, obese
patients had a greater LA size (44.2 6 5.7 mm) than over-
weight (41.6 6 5.9 mm) or normal weight (38.9 6 6.2 mm)
patients. Indexed LA size (Fig. 2, bottom) also differed signif-
icantly (p # 0.0001 by ANOVA) across obesity categories,
averaging 25.3 6 3.4 mm/m for obese, 23.6 6 3.3 mm/m for
overweight and 22.1 6 3.5 mm/m for normal weight patients
(all three groups significantly different by the Tukey proce-
dure). Left atrial enlargement was present in 55.8% of obese
patients, 42.2% of overweight patients and 25.0% of normal
Table 1. Baseline Covariates by Age and Race*
,55 Years 55 to 64 Years $65 Years
White
(n 5 81)
African-
American
(n 5 125)
White
(n 5 123)
African-
American
(n 5 166)
White
(n 5 86)
African-
American
(n 5 109)
Height (in.) 69.1 (2.4) 70.1 (2.5) 69.3 (3.4) 68.8 (3.5) 68.9 (2.4) 69.1 (3.2)
Weight (kg) 89.5 6 15.7 93.9 6 17.8 88.6 6 13.9 87.8 6 16.7 86.3 6 13.0 86.9 6 14.0
Body mass index (kg/m2) 29.0 (4.6) 29.5 (5.0) 28.6 (3.9) 28.7 (5.4) 28.0 (3.5) 28.2 (4.5)
LV diastolic dimension (mm) 51.0 (5.4) 51.8 (5.4) 51.3 (6.9) 51.2 (6.2) 51.1 (6.2) 50.1 (6.3)
Relative wall thickness 0.46 (0.09) 0.48 (0.10) 0.49 (0.11) 0.50 (0.10) 0.51 (0.11) 0.54 (0.15)
Septal thickness (mm) 12.2 (2.2) 12.7 (2.1) 12.8 (2.3) 12.9 (2.1) 13.1 (2.2) 13.6 (2.6)
Posterior wall thickness (mm) 11.3 (1.7) 11.9 (2.0) 11.9 (2.0) 12.2 (1.9) 12.3 (2.1) 12.8 (2.6)
LV mass (g) 236.4 (65.5) 259.0 (67.7) 259.4 (77.8) 261.2 (69.8) 266.1 (80.0) 272.4 (78.6)
*p 5 NS for all race comparisons within age groupings. Data are presented as mean value (SD). LV 5 left ventricular.
Figure 1. Bivariate correlations of
physiologic and LV structural descrip-
tors with LA size (dimension [open
bars]) and LA size indexed by height
(dotted bars). BMI 5 body mass in-
dex; DBP 5 diastolic blood pressure;
Ind. 5 indexed; LV dim. 5 LV dimen-
sion in diastole; Phys. act. 5 physical
activity index; Post. wall 5 posterior
wall thickness in diastole; PRA 5
plasma renin activity; SBP 5 systolic
blood pressure.
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weight patients (p , 0.005, all pairwise comparisons). The
average body mass index for patients with a normal LA size
was 27.6 6 4.0 kg/m2 in contrast to 30.4 6 5.0 kg/m2 for
patients with LA enlargement (p , 0.0001). Of patients with
LA enlargement, 45% were obese compared with 24% of
patients with a normal LA size.
Effect of obesity on relation between left ventricular mass
and left atrial size. Using two-way ANOVA, a significant
interaction (p5 0.02) was found between body mass index and
LV mass in their relation to LA size (Fig. 3, top). For normal
weight individuals, there was no relation between LV mass and
LA size. Left atrial size averaged 38.9 6 5.5 mm for patients
with LVmass,225 g, 38.76 6.9 mm for patients with LVmass
between 225 and 275 g and 39.16 6.8 mm for patients with LV
mass .275 g. For obese individuals, a significant relation was
found between LV mass and LA size. Left atrial size for
patients with LV mass ,225 g averaged 41.1 6 5.2 mm. By
pairwise comparison, this was significantly less than the aver-
age of 44.4 6 5.7 mm for patients with LV mass between 225
and 275 g, and 45.6 6 5.7 mm for patients with LV mass
.275 g.
Similarly, a significant interaction (p 5 0.003) was found
between body mass index and LV mass in their relation to
indexed LA size (Fig. 3, bottom). For normal weight individ-
uals, no relation between LV mass and indexed LA size was
found, whereas obese patients with LV mass ,225 g had
significantly (p , 0.05 pairwise comparison within ANOVA)
smaller indexed LA size compared with patients with LV mass
between 225 and 275 g and those with LV mass .275 g.
Relation between race, age and left atrial size. For men
,55 years, LA size (Fig. 4, top) averaged 41.1 6 5.5 mm for
whites compared with 41.0 6 6.4 mm for African-Americans.
In whites 55 to 64 years old, LA size averaged 42.7 6 6.6 mm
compared with 40.4 6 6.0 mm for African-Americans of
comparable age. Among men 65 years or older, LA size
averaged 43.9 6 6.9 mm in whites compared with 40.0 6
6.2 mm in African-Americans. Two-way ANOVA of age and
race and their interaction found the interaction to be signifi-
cant (p 5 0.01), indicating that the age relation to LA size
differed between races. Pairwise comparison found no race
difference among younger men but a significant difference
among the oldest group.
For indexed LA size (Fig. 4, bottom), two-way ANOVA of
age and race and their interaction also found the interaction to
be significant (p 5 0.04). Pairwise comparison indicated no
race difference among the younger patients but a significant
race effect in the oldest group. For men,55 years, indexed LA
size averaged 23.4 6 3.0 mm/m for whites compared with
23.0 6 3.5 mm/m for African-Americans. Among those 55 to
64 years old, indexed LA size averaged 24.3 6 3.7 mm/m for
whites compared with 23.2 6 3.6 mm/m for African-
Americans. In the oldest age group, the averages for indexed
LA size were 25.16 3.8 mm/m for whites and 22.86 3.7 mm/m
for African-Americans.
Combined effects of demographic, clinical and echocardio-
graphic descriptors on left atrial size and indexed size. Mul-
tiple regression analysis considering demographic, clinical and
echocardiographic characteristics was done to model LA size.
Figure 2. Relation of LA size (top panel) and indexed
LA size (bottom panel) to obesity category. Data are
presented as mean value 6 SD; p , 0.0001 by ANOVA.
By pairwise comparison, LA size is significantly greater
in obese patients than in normal weight or overweight
patients; indexed LA size is significantly increasing
across the three obesity categories.
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The following potential predictors were evaluated: body mass
index, age, race, systolic blood pressure, heart rate, physical
activity, plasma renin, sodium excretion, LV mass and relative
wall thickness. Two models were developed. The first evalu-
ated which of these variables were independently significant to
assess their relative importance in predicting LA size. In the
second model, all possible two-way interactions of the variables
selected in the first model were also considered. By conven-
tion, if an independent variable became nonsignificant with the
addition of the interaction terms, it was retained in the model
if it was also represented in a significant interaction.
The second model is presented in Table 2. Body mass index
was the most important predictor, explaining 13% of the
variation in LA size. This was followed, in descending order, by
race, LV mass–body mass interaction, age–race interaction,
age and LV mass. The final model explained 20% of the
variation in LA size. Body mass index and its interaction with
LV mass accounted for 76% of the variation explained by the
model.
A similar modeling process was done for indexed LA size.
Body mass index independently accounted for 15% of the
variation in indexed LA size. This was followed by race, age,
LV cavity dimension, age–race interaction, LV cavity
dimension–body mass index interaction, systolic blood pres-
sure, sodium excretion–body mass index interaction, race–LV
diastolic dimension interaction, sodium excretion and LV
diastolic dimension–sodium excretion interaction. The final
model explained 24% of the variation in indexed LA size. Body
mass index and its interactions with LV cavity dimension and
sodium excretion accounted for 68% of the variation explained
by the model.
Discussion
Although echocardiographic studies of hypertension have
evaluated the structure and function of the left ventricle,
effects of hypertension on the left atrium are also important.
Left atrial size is of clinical relevance for the occurrence of
atrial fibrillation (4), stroke (6,22) and congestive heart failure.
In an early echocardiographic study, Savage et al. (23) found
LA enlargement in 5% (in comparison with increased LV mass
in 51%) of hypertensive patients, even though mean LA size
was not increased. Left atrial dimension was weakly correlated
(r 5 0.20) with systolic blood pressure, as was LV mass (r 5
0.23). Another echocardiographic study of hypertension (Sys-
tolic Hypertension in the Elderly Program [SHEP]) found LA
enlargement on the echocardiogram in 51% of elderly patients
with systolic hypertension, but also in 30% of age-matched,
normotensive control subjects (3). It is uncertain, however,
whether the LA enlargement noted in these normotensive
Figure 3. Relation of LA size (top
panel) and indexed LA size (bottom
panel) to LV mass, cross-tabulated by
obesity category. Data are presented as
mean value 6 SD. By ANOVA, obesity
category modifies the relation of LV
mass to LA size (p 5 0.02) and indexed
LA size (p 5 0.003). By pairwise com-
parison, no relation was found between
LV mass and LA size and indexed LA
size for normal weight or overweight
patients. For obese patients, LA size is
significantly greater in patients with LV
mass $225 g than in patients with a
smaller LV mass.
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control subjects represented normal, age-related increases in
LA size in comparison with a younger reference group, or
pathologic increases in LA size consequent to impaired LV
filling or other degenerative cardiac changes. There were weak
but significant relations in the SHEP study between LA size
and LV mass indexed by body surface area (r 5 0.20), as well
as with relative wall thickness (r 5 0.31). In the Framingham
Study of a free-living cohort (7), blood pressure and LV mass
were both correlated with LA enlargement on the echocardio-
gram, although on multivariable analysis most of the variance
in LA dimension was explained by LV mass and body weight.
Our study extends the findings of the Framingham group in
noting that even in patients with established hypertension and
with a high prevalence of LV hypertrophy, obesity is nonethe-
less the most important predictor of LA size, LA size indexed
by height and LA enlargement. Moreover, obesity magnifies
the relation between LV mass and LA size. However, the
relation of systolic blood pressure to LA size is weak when
controlling for obesity, LV mass and race and their interac-
tions.
Race and left atrial size. Not noted in the Framingham
Study, possibly because of the relatively small proportion of
African-American subjects available for study, was our finding
of a relation between race and LA size in older hypertensive
Figure 4. Relation of LA size (top panel)
and indexed LA size (bottom panel) to
age, cross-tabulated by race. Data are pre-
sented as mean value 6 SD. By ANOVA,
race modifies the relation of age to LA
size (p 5 0.01) and indexed LA size (p 5
0.04). By pairwise comparison, LA size
and indexed LA size are significantly
smaller in African-Americans $65 years
old than in whites in the same age group.
No difference between African-Americans
and whites is seen in the younger age
groups.
Table 2. Stepwise Multiple Regression of Predictors of Left Atrial Size
Predictor Variable Estimate SEE Partial R2 p Value
Intercept 28.236 5.243 0.0001
Body mass index 0.225 0.163 0.1293 0.1677
LV mass 20.005 0.017 0.0280 0.7644
Age–race interaction 20.134 0.044 0.0110 0.0024
Posterior wall 20.329 0.146 0.006 0.0249
Age 0.126 0.035 0.0055 0.0003
Race 5.481 2.59 0.0037 0.0347
LV mass–body mass index
interaction
0.0008 0.0005 0.0024 0.1532
LV 5 left ventricular.
656 GOTTDIENER ET AL. JACC Vol. 29, No. 3
LEFT ATRIAL SIZE IN HYPERTENSIVE MEN March 1, 1997:651–8
men, even after adjustment for covariates. The finding of a
greater LA size and a higher prevalence of LA enlargement in
older white than in older African-American men is somewhat
surprising. In addition, the expected direct relation of age to
LA size was maintained only in white hypertensive men.
Although LV mass did not differ by race (8), relative wall
thickness, itself a predictor of outcome (24), was greater in the
African-American patients (8). Conceivably, in African-
American men, a parallel increase in LA wall thickness may
limit distensibility and hence cavity size of the left atrium.
Because LA wall thickness is not measurable by echocardiog-
raphy, this hypothesis is not testable in the present data set.
A recent preliminary report from the Cardiovascular
Health Study (25), which evaluated predictors of LA size in a
community-based cohort of 5,201 elderly subjects, also found a
greater LA size in whites than in African-Americans. This
relation retained significance even after adjustment for obesity,
blood pressure and LV mass. Notably, body mass index was
also the most important predictor of LA size, even in an elderly
cohort.
The present study evaluated a relatively large number of
hypertensive patients with a high proportion of African-
American participants. Hence, the study was sufficiently pow-
ered to determine the relative influences of clinical and LV
structural characteristics on LA size.
Study limitations. However, it is important to note several
limitations. Because men with a relatively high prevalence of
LV hypertrophy were evaluated, the findings of the present
study may not be generalizable to women or to patients with
less severe hypertensive disease.
Clinically important mitral regurgitation usually results in
LA dilation. Systematic Doppler examination was not per-
formed in the present study to determine the presence and
severity of coincidental mitral regurgitation. However, the
presence of clinically evident valvular heart disease was a
criterion for exclusion from the study. Hence, it is unlikely that
a sufficient number of patients with mitral regurgitation severe
enough to bias the results would have been recruited.
Much of the variation in LA size in this study was not
accounted for by the factors examined in the multivariate
models. However, in large-scaled studies it is not unusual to
see regression models that account for only a small part of the
variation in the response measured. Unmeasured factors that
may account for variation in LA size include biologic variability
of the subjects and methodologic variability in echocardio-
graphic acquisition, as well as other undiscovered factors that
might have a direct relation to LA size. Also, despite a positive
correlation of LA size to height, height-indexed LA size
displayed a negative correlation even after adjustment for
other covariates. This suggests that algebraic indexation of LA
size by height does not remove the influence of height from the
measurement.
Lastly, a single LA dimension obtained from M-mode
echocardiography, representing the anteroposterior diameter,
may not accurately reflect LA volume in all patients, particu-
larly if LA enlargement is restricted to superoinferior or
mediolateral planes. Also, in some patients, dilation of the left
atrium may occur asymmetrically or may be greatest distal to
the relatively proximal placement of the cursor in relation to
the mitral valve plane. However, the placement of the M-mode
cursor was guided by two-dimensional visualization of the LA
area in two orthogonal anatomic planes so as to traverse the
maximal diameter of the chamber. Hence, it is unlikely that
there was misrepresentation of the LA volume by inappropri-
ate placement of the M-mode cursor in a substantial number of
cases. Furthermore, preliminary data have suggested that even
in different disease states, LA enlargement occurs in all three
anatomic planes (26). In fact, numerous studies establishing
relations between LA size and biologic covariates have all
employed two-dimensional guided M-mode echocardiography
(2–7,22,27).
Clinical implications. Previously, the importance of obe-
sity in hypertension was underscored by its relation to the
prevalence and severity of hypertension as well as its indepen-
dent effect on LV mass, itself an important predictor of clinical
outcome. The present study extends these observations by
showing that LA size, also an important predictor of clinical
events, is strongly related to obesity. Moreover, obesity was the
strongest predictor of LA size, followed by LV mass, age in
whites and LV cavity size. In contrast, the effect of systolic
blood pressure was marginal, even in this hypertensive cohort
with a wide range of systolic blood pressures. In addition,
greater LA size in older white hypertensive men suggests the
possibility of enhanced morbidity associated with LA size (i.e.,
atrial fibrillation and embolic stroke).
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